MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

Boston BioBreak
Utah BioBreak
Philly BioBreak
Canada BioBreak
Big BIO BioBreak
BIO Europe BioBreak
New Jersey BioBreak
UK BioBreak
New York BioBreak
JPMorgan BioBreak
Sweden BioBreak
All Regions
Yes No
I agree with BioBreak's Privacy Policy

Refer a Friend

Reset Password

Boston BioBreak – Events Archive

Please see below for attendees and images from this event.

Boston Boston BioBreak Networking Happy Hour- March 7, 2019 March 7, 2019 5:30-7:30 pm

Attendees at this event

Mahmoud Mahmoudian Sumitomo Pharma
Jamil Beg 5AM Ventures
Jordan Leef Pyramid Biosciences Inc
Jeff Behrens Siamab Therapeutics
Ted Hibben Cerevance
Greg Miller Visterra
Tom Needham Broadview Ventures, Inc.
Catherine Lenich Beth Israel Deaconess Medical Center
Yukari Perrella Yuma Therapeutics
Marcelo Cheresky Bioverativ
Douglas MacDougall MacDougall Biomedical Communications
Catherine Thut Novartis Institutes for BioMedical Research
Bonnie Fendrock Cyta Therapeutics
Brad Carver SynDevRx
Rick Lundberg Navitor Pharmaceuticals
Yuan-Hua Ding Ding Pfizer
Paul Juniewicz Takeda Oncology
Alan Kugler Coastal Pharma Group
Eric Elenko PureTech Ventures
Michal Preminger Harvard University
David Brush Novartis Institutes for BioMedical Research
Gordon Jamieson Translational Therapeutics
Kathryn Gregory Seneb BioSciences, Inc.
PJ Anand Alcyone Lifesciences
John Gustofson AbbVie
Barbara Fox Tilos Therapeutics
Mark Fraga Shire
John Dunlop Amgen
Avi Spier Novartis
Jonathan Bloom Podimetrics
John Schwartz AcuityBio
Jeff Imbaro Semma Therapeutics
Ed Mascioli EMMD LLC
Arthur Hiller Antyllus Therapeutics
Jim Weissman Dicerna
Scott Edwards SciFluor Life Sciences
Kristen Albright Prokarium
susan ward Dr.
Markus Haeberlein Alkermes
Tom Andrews Alexandria Real Estate Equities
Mark Carthy Orion Equity Partners
Derek Lee Athyrium Capital
Geoffrey Horwitz Decibel Therapeutics
Andy Meyerson Locust Walk
Jens Eckstein SR One
Brendan Downey Takeda
Michael Boretti Epizyme
Bob Havard Signet healthcare
Ryan Dietz Boston Children's Hospital
Adrian Bignami Vertex
John Tagliamonte WntRx
Chris Kim Novatio Ventures
John Delyani Tmunity
Neil Swami Catalyst Health Ventures
Ross Leimberg AbbVie Ventures
Tanja-Stephanie Weber Agios
James Shanahan SynDevRx, Inc.
Georg Nebgen Vivant Holdings
Bob Palladino Bionevia LLC
James Gorman Startup Mode
Alan Roemer Roivant Sciences
Lizabeth Leveille Merck
Daniel Krizek Citadel / Surveyor
Adam McNulty Chiesi Group
David Standring
Maude Tessier Kyn Therapeutics
Roman Fleck Janpix
Michael Shih Sanofi
Jen Rice Harvard University
Stephen Potter AGTC
Gaye Bok Orionis Biosciences Inc.
Patrick Tricoli NANOBIOTIX US
Stephen Seiler Windgate Partners
Andrew meadow Excelyrate Capital
Fumitaka Mori Remiges Ventures
Tarik Soliman Extend Biosciences
Girish Aakalu Genocea Biosciences
Chris Gemmiti Sentien Biotech
Guillermo Rubio AMAG Pharmaceuticals
James Harper Sonde Health
Jennifer Wheler Merriman Gardner Group
Catherine Nuccio Alexandria Venture Investments
Christopher Scannell InsideOutBio
Stephen Curtis MPM Capital
Christian Cortis Agenus
Daniel Macaya 5AM
Ted Marple Acworth Pharmaceuticals, Inc.
David Sherris GenAdam Therapeutics
Chieze Ibeneche-Nnewihe RA Capital
Bruce Beutel Dewpoint Therapeutics
Amanda Kay Synlogic
Katie Ellias JDRF T1d Fund
Mark Currie Ironwood Pharmaceuticals
Ivan Hyep Third Rock Ventures
Rodolphe Clerval ENTEROME
Greg Fralish Takeda Oncology
Julia Keith RA Capital
Yury Kukushkin 4biocapital
Manav Mehta Gel4Med
Peng Leong Engine Biosciences
Barbara Sosnowski Pfizer
Will Andrews Aletheia Lifesciences
Maria Zlyhastseva BioBreak
Patrick Rivelli MIT Angels
Jim Ellis Nocion Therapeutics
Diala Ezzeddine Xios Therapeutics
Alan Ginsberg Takeda
Ram Aiyar Corvidia Therapeutics
Anthony Walsh BioInnovation Capital
Lucas de Breed INKEF Capital
Bryan Lord Orthopedic Venture Partners
Bill Whelan Mintz Levin
A.J. Kumar Jana Care
Laura Stoppel RA Capital Management
Olga Danilchanka MRL Ventures
Meg Krench RA Capital Management
Eric Evans Mass Medical Angels
Evan Thompson Abcuro
Shawn Marcell ReadCoor
Komal Joshi Jounce Therapeutics
Jeff Stevens Puretech Health
Larry Cai Fosun
Jason Ruth 5AM Ventures
Kathryn McCabe Eli Lilly
Chris Hurff Takeda
Nevin M. Summers MIT Synthetic Biology Center
Benjamin Sigel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Laura Tadvalkar MP Healthcare Venture Management
Kerrie Brady Cetrexion Therapeutics
Ben Dake RA Capital
Tiffany Kelley Nightingale Apps LLC
Victor Shifrin ImmunoChem Therapeutics
Jin Ji PulchriBio
Arkesh Mehta OncoBindi Therapeutics
Thomas Leggett Axcella Health
Sophie de Boer Flagship Pioneering
Julien Pham Genprex
Thurein Htoo Qrativ
Rosy Hu Partners Innovation Fund
Laszlo Kiss Pfizer
Isabella Zhang JDRF T1D Fund
Alex Nichols Mythic Therapeutics
Adam Buckley VBI Vaccines Inc
Kim Seth Repare Therapeutics
Brian Fiske Mythic Therapeutics
Christine Brennan MRL Ventures Fund
Kathryn McAllister Merck
Fred Chereau LogicBio
Tom Wilton LogicBio
Devin Quinlan MPM Capital
Rakhshita Dhar Roche
John Parker Springhood Ventures
Lori Kaiser Halloran Consulting Group
Samuel Inverso Readcoor
Barbara Hibner PercepTx
Stephanie Oestreich Evotec
Andrew Gengos AOBiome
Marc Schwabish Fusion Pharma
Sathya Elumalai Multisensor Diagnostics
Albert Hsia Merck
Alex Ray Boston Millennia Partners
Sabrina Yang Flagship Pioneering
Thomas Collet Phrixus Pharmaceuticals, Inc.
Bernhard Guenther Novaliq Inc.
Theonie Anastassiadis Flagship Pioneering
Luba Greenwood Google
Benjamin Kreitman Broadview Ventures
David Tabaczynski Phion Therapeutics
Baruch Harris Metera
Christopher Gagliardi Sanofi Ventures
Melissa McCracken Third Rock Ventures
Michael Egholm Danaher Life Sciences
Kelly Moynihan Third Rock Ventures
Juan Garcia BioSeed Capital
Chris Seitz Excel Venture Management
Peter Dudek MRL Ventures Fund
Uciane Scarlett Atlas Venture
Samuel Murphy Salubris Pharma
Lance Ostrom Roche
Tomer Cohen Locust Walk
Scott Robinson MicroQuin
Jamie Kasuboski Boehringer Ingelheim Venture Fund
Isabelle Gorrillot, PhD Fortress Biotech
Brian Fenton Translate Bio
Yasaman Soudagar Neurescence Inc.
rosemary harrison RA Capital
Rajeev Chillakuru Elstar Therapeutics, Inc
Jaideep Dudani Vida Ventures
Adam Friedman Vivid Biosciences
Cheryl Nickerson-Nutter Hulow Medical
Debbie Lin Boehringer Ingelheim
Eric S. Hoffman, PhD Boulevard Consulting
Frederic Sweeney Northern Biologics
John Hennessey Boston Harbor Angels
Meghan Wood CureDuchenne
Adam Cohen Broadview Ventures
Ross Castillo JDRF T1D Fund
Eric Snyder Novo Ventures
Brooke Paige Pear Therapeutics
Brian Coleman Locust Walk
Philip Gotwals Novartis
Michael Woo Novartis
Christina Hedberg MIT TLO
Todd Woodworth BioInovation Capital
Elizabeth Reczek Ravello Precision Partners
Mariana Nacht Vivid Biosciences
Nicholas McCray Sanofi-Genzyme
Krista mckerracher Crispr Therapeutics
Vered Bisker Compass
Maria vilenchik Felicitex Therapeutics, Inc.
Jonathan Friedlander Digitalis
Bo Rode Hansen Genevant Sciences
Christine Bunt Verseau Therapeutics
David Lee Servier Pharmaceuticals
Darren Link TorpedoDx
Parag Mehta AVETA BIOMICS, INC.
Imran Babar Cydan
barry ticho Stoke Therapeutics
Daniel Rippy Lantheus Medical Imaging
Poorya Hosseini Flagship Pioneering
Jennifer Beachell Beachell Consulting, LLC
Yaniv Bejerano Innate Biotherapeutics
Blair Lapointe Merck & Co.
Vera Hoffman Reveal Pharmaceuticals
Partha Paul Lpixel, Inc.
Leslie Loveless Slone Partners
Mingfu Zhu Panorama Medicine
Partha Chakrabarti Sanofi Genzyme
Diana Bernstein MRLV
Andrew Warren Third Rock Ventures
Jonathan McNeill Dyne Therapeutics
Chip Clark Genocea Biosciences
Christopher Scannell InsideOutBio, Inc.
Karla MacDonald Ipsen
Anant chopra Bayer
Jerry Williamson NanoView Biosciences
John Kehoe Ipsen
Michael Palladinetti Sanofi Genzyme

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com